Judge Pauses Pradaxa Lawsuits To Assign Lead Attorneys

Share Article

The Web’s largest source for information on Pradaxa legal news, research and side effects is available at The Pradaxa Resource Center. Visit http://www.Pradaxa-lawsuits.org

Pradaxa lawsuit
Anyone affected by internal bleeding or the loss of a loved one from Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.

The patient advocates at the Pradaxa Resource Center are alerting those who took the blood thinner Pradaxa that the drug has been linked to severe internal bleeding. A federal judge recently ruled that lawsuits by those injured may proceed after lead attorneys are assigned.

Anyone affected by internal bleeding or the loss of a loved one from Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, the drug has earned over $1 billion for manufacturer Boehringer Ingelheim and has been used in over 70 countries for the year ending February, 2012, according to a Wall Street Journal report on April 24, 2012.

On December 7, 2011, however, the FDA warned that it would launch an investigation into Pradaxa after receiving more injury or death reports than expected. According to a USA Today article on August 19, 2012, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users last year, leading all other medications in 2011.

Due to the number of claims expected, a central court was recently established in Illinois to handle the lawsuits. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. On July 25th, Judge David Herndon issued an order stating Pradaxa lawsuits may proceed despite attempts by Boehringer Ingelheim to have them dismissed.

The United States Judicial Panel on Multidistrict Litigation indicated on September 5, 2012 that more than 100 Pradaxa side effect claims have now been filed. Judge Herndon has also set an initial hearing for October 3rd and indicated trials should start in 18 to 24 months. However, the judge also issued a stay on September 12, 2012 pausing litigation until lead counsel may be assigned.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about a potential Pradaxa lawsuit and their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.

To speak with a lawyer, or for more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, visit http://www.Pradaxa-lawsuits.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website